## ROP: Roper Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -1.9% below STRENGTH zone (4.0-10.0%); PEG 1.98 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (57% of avg), momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($420.14)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Roper Technologies Stock: Quiet Strength Behind the Ticker as Wall Street Edges More Bullish**
- Source: AD HOC NEWS | 20260102T164156 | Bullish | Relevance: 100%
- Roper Technologies, a disciplined operator, is trading close to its 52-week highs, showing quiet strength amid market struggles for cyclical names. The company benefits from software-like margins, active portfolio reshaping, and positive analyst calls, with its stock showing steady compounding gains for long-term shareholders despite modest daily volatility. Wall Street analysts are broadly bullish, seeing Roper as a high-quality, asset-light cash machine in the industrial and software universe, with further upside potential due to its focused strategy on niche software and technology businesses.

**2. Roper Technologies Stock: Quiet Strength Behind the Ticker as Wall Street Edges More Bullish**
- Source: AD HOC NEWS | 20260102T170819 | Bullish | Relevance: 100%
- Roper Technologies (NYSE: ROP) has consistently performed well, quietly appreciating while many cyclical stocks struggled. The company's focus on software-like margins, active portfolio management, and positive analyst outlooks have pushed its stock close to 52-week highs. Investors are now questioning whether the recent consolidation is a temporary pause before further gains or if expectations have outpaced fundamentals.

**3. The Truth About Roper Technologies: Is This ‘Boring’ Stock Secretly a Monster Win?**
- Source: AD HOC NEWS | 20260102T170800 | Bullish | Relevance: 100%
- Roper Technologies, a seemingly "boring" tech conglomerate, has been quietly generating significant gains in the stock market. The article delves into Roper's business model, stock performance, and why it's favored by long-term investors despite not being a mainstream trending stock. It evaluates whether Roper is a smart investment for those seeking steady growth over short-term spikes.

**4. Ethic Inc. Sells 2,721 Shares of Roper Technologies, Inc. $ROP**
- Source: MarketBeat | 20251231T092218 | Somewhat-Bullish | Relevance: 100%
- Ethic Inc. reduced its stake in Roper Technologies (NASDAQ:ROP) by 20.3% in the third quarter, while several other institutional investors modified their holdings. Analysts have a "Moderate Buy" rating with an average target price of $572.14, and Roper recently increased its quarterly dividend to $0.91. Insiders, including CEO Laurence Neil Hunn and Director Amy Woods Brinkley, have also recently purchased shares, showing increased ownership.

**5. Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain?**
- Source: TradingView — Track All Markets | 20251231T150742 | Somewhat-Bullish | Relevance: 70%
- Nordson Corporation's Medical and Fluid Solutions segment experienced a 7.4% organic sales increase in Q4 fiscal 2025, driven by demand in medical interventional products and fluid solutions, contributing to a 40 basis point EBITDA margin rise. The acquisition of Atrion Corp. further expanded its medical offerings, leading to a bullish fiscal 2026 outlook with expected sales of $2.83-$2.95 billion. Nordson (NDSN) shows a Zacks Rank #2 (Buy) and has outperformed its industry in stock performance over the past three months.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Goldman Sachs | $507 | $572 | -11% |
| 2025-12-04 | Barclays | $475 | $506 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Goldman Sachs | main | Neutral |
| 2025-12-04 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($2.47M) |
| Sells | 2 ($0.77M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.8%)
- Blackrock Inc.: 8.6% (-2.1%)
- State Street Corpora: 4.7% (+0.9%)
- Morgan Stanley: 3.7% (+6.8%)
- JPMORGAN CHASE & CO: 3.0% (+225.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.0% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 16.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.98 elevated, pricing in significant growth expectations. Forward P/E 20.1x stretched relative to 8% growth. Quality metrics strong (margin 20%). Analyst sentiment negative (2 target cuts vs 0 raises). Insider buying signal ($2.5M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.8B |
| Beta | 0.94 |
| 52W Range | $428.19 - $595.17 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.98 |
| Forward P/E | 20.1 |
| Current P/E | 21.8 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.0% to -1.9% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.83x), long-term trend not supportive. Volume at 57% of 20MA suggests lack of conviction. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.93% (CS: 20) | Neutral |
| RSI_14 | 33.7 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 0.973x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.832x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $434.54
- **Stop Loss:** $420.14 (3.3% risk)
- **Target:** $448.94 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $36,066.82
- **Portfolio %:** 36.07%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $5.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.11 | $5.14 | +0.6% |
| 2025Q2 | $4.83 | $4.87 | +0.8% |
| 2025Q1 | $4.74 | $4.78 | +0.8% |
| 2024Q4 | $4.73 | $4.81 | +1.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*